Efficacy and safety of first-line gefitinib treatment in...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Efficacy and safety of first-line gefitinib treatment in metastatic lung adenocarcinoma patients with sensitizing EGFR mutation determined by ddPCR in plasma cell-free DNA (BENEFIT trial)

Wang, J., Cheng, Y., Wu, Y-L., An, T., Gao, H., Wang, K., Zhou, Q., Hu, Y., Song, Y., Ding, C., Ye, X., Peng, F., Liang, L., Hu, Y., Huang, C., Zhou, C., Shi, Y-K., Zhang, L., Gu, Y.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.88
Date:
October, 2016
File:
PDF, 34 KB
english, 2016
Conversion to is in progress
Conversion to is failed